Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ANI PHARMACEUTICALS INC Director's Dealing 2015

Mar 16, 2015

31676_dirs_2015-03-16_d6fa6e1e-f483-468f-97cb-54dc198c7ac5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2015-03-12

Reporting Person: Arnold Charlotte C. (Vice President and CFO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-03-12 Common Stock S 45000 $63.00 Disposed 21385 Direct

Footnotes

F1: Shares sold for estate and tax planning purposes.